American Century Companies
TGTX icon

American Century Companies’s TG Therapeutics TGTX Stock Holding History

American Century Companies’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$216K Buy
+3,933
New +$161K ﹤0.01% 2763
2024
Q4 		– Sell
-10,209
Closed -$239K – 2953
2024
Q3 		$239K Buy
+10,209
New +$223K ﹤0.01% 2720

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

American Century Companies's TGTX Position: Q2 2026 in Review

American Century Companies opened a new position in TG Therapeutics (TGTX) in Q2 2026: 3,933 shares worth $216K. The stake represents ﹤0.01% of the portfolio and ranks #2763 among its holdings. This is a return to the name: American Century Companies previously reported a position in TGTX as recently as Q3 2024.

American Century Companies first reported a position in TGTX in Q3 2024 and has held it in 2 quarters since. The position peaked at $239K in Q3 2024. 430 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • American Century Companies held 3,933 shares of TG Therapeutics worth $216K as of Q2 2026.
  • TG Therapeutics was a new American Century Companies position in Q2 2026.
  • TG Therapeutics made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2763 holding.
  • American Century Companies first reported a position in TG Therapeutics in Q3 2024 and has held it in 2 quarters since.
  • American Century Companies's TG Therapeutics position peaked at $239K in Q3 2024.
  • 430 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.